In a significant move to boost infection prevention capabilities nationwide, 54 hospitals have been awarded funding to bolster preparation for special pathogens. The grants were provided by The National Emerging Special Pathogens Training and Education Center (NETEC), aiming to create a nation-wide network of facilities committed to readying for, carefully monitoring, and treating high-consequence infections, including diseases of unfamiliar origin.
Each beneficiary hospital could receive up to $500,000. The awarded funds are intended specifically for infrastructure enhancements, specialized equipment purchases, and workforce training. This assistance is instrumental for these facilities in order to meet the requirements set by the National Special Pathogen System Level 2 Special Pathogen Treatment Center standards, as explicated in a January 6th news release from the institution.
The Administration for Strategic Preparedness and Response, a subsection of the Department of Health and Human Services (HHS), is overseeing the disbursement of funds. In total, $37.5 million has been allocated for this program, making it one of the most generous federal contributions towards special pathogen preparedness to date.
The corresponding hospitals have a critical role to fulfil within the federally coordinated, tiered framework for special pathogen care. These facilities will not only be responsible for providing extensive inpatient care throughout a patient’s full illness course, but they must also maintain stringent infection prevention and control regulations for patients suffering from high-consequence infectious diseases.
The 54 selected hospitals, which stretch across 28 states and various U.S. territories, will considerably strengthen the National Special Pathogen System. This initiative delivers a robust, collaborative strategy in the field of infection prevention, emphasizing the urgent need for high-standard disease surveillance and control measures.
Byron Jobe, the CEO and president of Vizient, stated on February 25 that “systemness,” not scale, will define healthcare’s next era. He emphasized the importance of blending procurement decisions with a hospital’s overall performance strategy to ensure patient safety and maintain CMS accreditation. Only then could we mitigate the risk of substantial infectious diseases and prepare for pathogenic threats of unknown origin.